4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
YD Bio Ltd (YDES) operates in the Biotechnology industry and is headquartered in Taipei, Taiwan. Its market capitalization is roughly $152 million. In the fiscal year ended 2025-12-31, YDES reported $1M in revenue and ($8M) in net income.
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
Interactive charts & full statements → Open the YDES valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Revenue | $1M | $0M | $0M |
| Gross Profit | $0M | $0M | $0M |
| Operating Income (EBIT) | ($5M) | ($2M) | $0M |
| Net Income | ($8M) | ($1M) | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Assets | $14M | $7M | $0M |
| Total Liabilities | $17M | $0M | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive YDES viewer.
About TickerBase · Data methodology & sources